文献速递血液透析通路

牛颈动脉移植物与PTFE移植物用于血液透析通路的系统评价与荟萃分析

Bovine Carotid Artery Grafts versus PTFE Grafts for Hemodialysis Access: A Systematic Review and Meta-Analysis.
PubMed 文献 · Ann Vasc Surg · 2025-08-18

该系统评价与荟萃分析比较了牛颈动脉移植物(BCAG)与聚四氟乙烯(PTFE)移植物用于血液透析通路的临床结局。

要点

  • BCAG与PTFE感染率相似(64 vs. 95/1000患者年,P=0.43)。
  • BCAG 12个月一期通畅率显著高于PTFE(47% vs. 29%,P=0.02)。
  • BCAG 12个月一期辅助通畅率显著高于PTFE(66% vs. 34%,P=0.004)。

核心结论

  • BCAG在血液透析通路中相比PTFE移植物表现出更优的一期和一期辅助通畅率。
  • 其他结局也倾向于BCAG但无统计学显著性。
  • 需要大规模随机对照试验进一步明确BCAG的作用。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、Embase和Cochrane Library(PROSPERO注册号607603)。
  • 排除2000年以前发表的研究;采用随机效应模型进行荟萃分析和亚组分析。

主要发现

  • 感染率在BCAG与PTFE之间相似(64 vs. 95每1000患者年;P=0.43)。
  • 12个月时BCAG的一期通畅率显著更高(47% vs. 29%;P=0.02)。
  • 12个月时BCAG的一期辅助通畅率显著更高(66% vs. 34%;P=0.004)。
  • 12个月时BCAG的二期通畅率无显著更高(78% vs. 57%;P=0.10)。
  • 术后并发症发生率无差异。

临床怎么用

  • 对于无合适静脉建立动静脉瘘的患者,BCAG可作为PTFE移植物的替代选择。
  • BCAG可能改善一期和一期辅助通畅率,但需权衡个体化获益。
  • 当前证据尚不足以支持常规优先推荐BCAG,需等待大规模随机对照试验结果。

局限性

  • 纳入研究以队列研究为主,仅1项随机对照试验,证据等级有限。
  • 样本量较小(共1247例),可能影响次要结局的统计效能。
  • 原文未报告其他具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arteriovenous grafts are considered for hemodialysis access in patients without a suitable vein for the creation of an arteriovenous fistula (AVF). The most commonly used synthetic polytetrafluorethylene (PTFE) graft carries a high risk of infection (6-29%) and limited biocompatibility. The bovine carotid artery graft (BCAG), a biological alternative, may address these limitations. This systemic review and meta-analysis compared the clinical outcomes of BCAG versus PTFE grafts. METHODS: MEDLINE, Embase, and Cochrane Library were searched for eligible studies (PROSPERO, no. 607603). Studies including patients with BCAG access were included, and those studies published before 2000 were excluded. If PTFE outcomes were reported, they were pooled for comparison. The primary outcome was (graft) infection. Secondary outcomes included primary, primary assisted and secondary patency, and postoperative complications. Meta-analyses and subgroup analyses used random-effects models. RESULTS: Eleven studies (one randomized controlled trial (RCT) and 10 cohort studies) involving 1,247 patients met the inclusion criteria. Infection rates were similar between BCAG and PTFE (64 vs. 95 per 1,000 patient years; P = 0.43). At 12 months, BCAG showed significantly higher primary (47% vs. 29%; P = 0.02) and primary assisted patency (66% vs. 34%; P = 0.004). Secondary patency at 12 months was not significantly higher in the BCAG group (78% vs. 57%; P = 0.10). No differences were observed in the incidence of postoperative complications. CONCLUSION: BCAG demonstrated superior primary and primary assisted patency compared to PTFE grafts in hemodialysis access. Other outcomes also favored BCAG but lacked statistical significance. Large-scale RCTs are warranted to further define the role of BCAG and support evidence-based decisions.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kraai TW, Looman RS, Drouven JW, et al. Bovine Carotid Artery Grafts versus PTFE Grafts for Hemodialysis Access: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2025. PMID: 40835200. doi:10.1016/j.avsg.2025.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。